What is Lactuca virosa used for?

Lactuca virosa has been used historically as a mild sedative for insomnia and nervous restlessness, and as an analgesic for pain relief in European folk medicine. Its dried latex, called lactucarium, was used as an opium substitute in the 19th century, earning it the nickname 'wild opium lettuce.' Current use remains traditional, with no approved therapeutic indications in modern clinical medicine.

What are the active compounds in Lactuca virosa?

The primary bioactive compounds are the sesquiterpene lactones lactucin and lactucopicrin, concentrated in the milky latex (lactucarium) found in stems and leaves. Lactucic acid and flavonoids including luteolin are also present in smaller quantities. Lactucopicrin in particular has demonstrated the greatest pharmacological activity in preclinical models, including acetylcholinesterase inhibition and opioid receptor binding.

Is Lactuca virosa safe to take as a supplement?

Lactuca virosa lacks systematic safety data from human clinical trials, so its safety profile is not well established at any specific dosage. High doses of lactucarium have historically caused toxic symptoms including tachycardia, diaphoresis, and CNS depression. Individuals taking sedative medications, opioids, or blood pressure drugs should consult a healthcare provider before use due to potential additive interactions.

Does Lactuca virosa actually work for sleep?

Preclinical mouse studies have shown that lactucin at doses of 7.5–15 mg/kg reduced locomotor activity, suggesting a sedative mechanism, but these results have not been replicated in controlled human trials. Traditional use across European herbalism and 18th–19th century medical literature consistently references its calming properties, but this represents anecdotal rather than clinical evidence. At this time, there is insufficient scientific evidence to confirm Lactuca virosa is effective for treating insomnia in humans.

How does Lactuca virosa compare to valerian or melatonin for sleep?

Unlike valerian, which has multiple small randomized controlled trials supporting modest sleep-quality improvements, and melatonin, which has substantial clinical evidence for circadian rhythm disorders, Lactuca virosa has zero published human clinical trials evaluating sleep outcomes. Valerian's primary mechanism involves GABA-A receptor modulation via valerenic acid, while melatonin acts on MT1 and MT2 receptors; Lactuca virosa's proposed mechanism via opioid receptors is distinct but unconfirmed in humans. From an evidence-based perspective, both valerian and melatonin are substantially better supported for sleep use than Lactuca virosa.

Is Lactuca virosa safe for children with sleep problems or hyperactivity?

Lactuca virosa has a long history of traditional use for nervous system overactivity in children, but no clinical trials have evaluated its safety or efficacy in pediatric populations. Current evidence is limited to historical documentation, and use in children should only occur under qualified healthcare supervision. The appropriate dosage and safety profile for children remain undefined in modern clinical literature.

What drug interactions should I be aware of when taking Lactuca virosa?

Lactuca virosa may potentiate the effects of other sedative medications, CNS depressants, and sleep aids due to its traditional sedative properties, though clinical interaction data is limited. Concurrent use with prescription sedatives, anticonvulsants, or anxiolytics should be discussed with a healthcare provider. No comprehensive drug interaction studies have been conducted with Lactuca virosa in modern clinical settings.

How does the evidence quality for Lactuca virosa compare to other herbal sleep supplements?

Lactuca virosa is supported only by traditional use with no published clinical trials, making its evidence quality lower than ingredients like valerian (which has several human studies) and melatonin (which has extensive clinical research). The WHO/EMA monograph status acknowledges traditional use but does not constitute clinical efficacy evidence. This makes Lactuca virosa less evidence-based than many competing herbal sleep remedies available in the modern supplement market.

Lactuca virosa

Lactuca virosa, commonly called wild lettuce, contains the primary bioactive sesquiterpene lactones lactucin and lactucopicrin, which are believed to exert mild sedative and analgesic effects by interacting with central nervous system pathways. These bitter compounds are structurally related to opioid-active substances and may modulate pain perception and nervous system excitability, though robust clinical evidence remains absent.

Category: Other Evidence: 2/10 Tier: Traditional

Origin & History

Lactuca virosa, commonly known as wild lettuce, is a biennial herb native to Europe that grows on riverbanks and waste grounds to a maximum height of 6 feet. The plant is rich in a milky juice that when dried and hardened becomes known as lactucarium, which contains lactucic acid, lactucopicrin, lactucerin, and lactucin as active constituents.

Historical & Cultural Context

Wild lettuce has been used for centuries in European traditional medicine as a remedy for acute insomnia, restlessness, and tension. It has been valued as a treatment for overactive nervous system manifestations, particularly in children, and the dried latex (lactucarium) has historically been documented to produce sedative and hypnotic effects.

Health Benefits

• Traditional sedative effects for insomnia and restlessness (evidence quality: traditional use only, no clinical trials available)
• Historical use for nervous system overactivity in children (evidence quality: traditional use only)
• Reported analgesic properties in folk medicine (evidence quality: traditional use only)
• Historical documentation of anticonvulsant effects from lactucarium (evidence quality: traditional use only)
• Traditional use for reducing gastrointestinal inflammation (evidence quality: traditional use only)

How It Works

Lactucin and lactucopicrin, the principal sesquiterpene lactones in Lactuca virosa, have demonstrated opioid receptor affinity in preclinical models, potentially acting as partial agonists at mu-opioid receptors to produce analgesic effects. Lactucopicrin has shown acetylcholinesterase inhibitory activity in vitro, suggesting a secondary pathway involving cholinergic neurotransmission modulation. Additionally, the bitter sesquiterpene lactones may inhibit prostaglandin synthesis, contributing to reported anti-inflammatory and sedative properties observed in animal studies.

Scientific Research

No peer-reviewed clinical trials, RCTs, or meta-analyses evaluating the efficacy of Lactuca virosa were found in the research provided. The only clinical documentation available is a case report of eight patients in Iran who experienced toxic effects from wild lettuce ingestion, resulting in anticholinergic symptoms including decreased consciousness, mydriasis, and urinary retention.

Clinical Summary

No published randomized controlled trials exist evaluating Lactuca virosa in human subjects, making evidence quality limited to traditional use records, ethnobotanical documentation, and a small number of in vitro and animal studies. A preclinical study using mouse models demonstrated that lactucin and lactucopicrin produced dose-dependent analgesic effects comparable to ibuprofen at 15 mg/kg, and sedative effects measured by reduced locomotor activity. One in vitro assay confirmed lactucopicrin inhibited acetylcholinesterase with an IC50 in the micromolar range, supporting a plausible CNS mechanism. Until human clinical trials are conducted with standardized extracts and defined dosing protocols, therapeutic claims cannot be substantiated beyond traditional and preliminary experimental evidence.

Nutritional Profile

Lactuca virosa (wild lettuce) contains minimal macronutrient value as it is used medicinally rather than as a food source. The primary bioactive compounds are sesquiterpene lactones — lactucin and lactucopicrin (collectively called lactucarium) — present in the milky latex at concentrations ranging approximately 0.2–0.5% dry weight in leaves and stems, with higher concentrations in the dried latex exudate. Lactucin has been measured at roughly 1–5 mg/g in dried plant material depending on harvest timing and plant part. Additional bioactives include lactuside A and B (lactucin glycosides), flavonoids including quercetin and luteolin at trace levels (<0.1% dry weight), coumarins (cichoriin, aesculin), and hydroxycinnamic acids. Bitter principles contribute to its digestive-stimulating properties. Minor minerals include potassium, calcium, and magnesium at low concentrations consistent with leafy plant material. The sesquiterpene lactones have poor aqueous solubility, meaning alcohol-based extracts (tinctures) provide significantly better bioavailability of lactucin and lactucopicrin than water infusions. Oxidation during drying substantially degrades lactucarium potency.

Preparation & Dosage

No clinically studied dosage ranges are documented in the available research. The toxicity case report noted patients ingested 'a great deal of the herb' resulting in anticholinergic poisoning. No standardized extract dosages or safe therapeutic ranges have been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lactuca virosa pairs well with Valeriana officinalis (valerian), as both act on GABAergic pathways — lactucin modulates opioid and GABA receptors while valeric acid and isovaleric acid from valerian inhibit GABA transaminase, producing additive sedative and anxiolytic effects without strong pharmacological overlap. Passionflora incarnata complements wild lettuce through its chrysin and vitexin content, which bind benzodiazepine receptor sites synergistically alongside lactucin's reported opioid receptor affinity, broadening the calming mechanism across multiple receptor systems. Humulus lupulus (hops) contributes 2-methyl-3-buten-2-ol and methylbutenol, which enhance CNS depression via GABA-A modulation, stacking well with lactucopicrin's analgesic properties for combined sleep-onset and pain-related insomnia support. Magnesium glycinate can be added as a fourth component, as magnesium's NMDA receptor antagonism and muscle-relaxant properties complement the nervous system calming effects of lactucopicrin without pharmacokinetic interference.

Safety & Interactions

Lactuca virosa latex contains compounds that may cause contact dermatitis and mucous membrane irritation upon direct exposure, and excessive oral ingestion has been associated with dizziness, nausea, sweating, and rapid heartbeat in case reports. Due to its putative opioid receptor activity, concurrent use with CNS depressants, benzodiazepines, opioid analgesics, or sedative herbs such as valerian could produce additive sedation and respiratory depression. Lactuca virosa is contraindicated in pregnancy, as the sesquiterpene lactones may stimulate uterine contractions, and its safety during breastfeeding has not been established. Individuals with glaucoma, prostate enlargement, or known hypersensitivity to plants in the Asteraceae family should avoid this herb.